Development and validation of a symptom assessment tool for postmicturition dribble: A prospective, multicenter, observational study in Korea

Autoři: Hyun Cheol Jeong aff001;  Kyung Tae Ko aff001;  Dae Yul Yang aff001;  Won Ki Lee aff002;  Sang Kon Lee aff002;  Sung Tae Cho aff003;  Cheol Young Oh aff004;  Jin Seon Cho aff004;  Jong Keun Kim aff005;  Jun Hyun Han aff005;  Min Soo Choo aff005;  Seong Ho Lee aff005
Působiště autorů: Department of Urology, College of Medicine, Hallym University, Kangdong Sacred Heart Hospital, Seoul, Korea aff001;  Department of Urology, College of Medicine, Hallym University, Chuncheon Sacred Heart Hospital, Chuncheon, Korea aff002;  Department of Urology, College of Medicine, Hallym University, Kangnam Sacred Heart Hospital, Chuncheon, Korea aff003;  Department of Urology, College of Medicine, Hallym University, Hallym University Sacred Heart Hospital, Anyang, Korea aff004;  Department of Urology, College of Medicine, Hallym University, Dongtan Sacred Heart Hospital, Hwaseong, Korea aff005
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article
doi: 10.1371/journal.pone.0223734



Postmicturition dribble (PMD) is a very common symptom in males with lower urinary tract symptoms (LUTS) worldwide, but there is no adequate questionnaire to assess it. Therefore, we developed a questionnaire named the Hallym Post Micturition Dribble Questionnaire (HPMDQ) to assess PMD, and the aim of this study is to validate it.


A series of consecutive male patients newly diagnosed with LUTS and over 40 years of age who visited any of 5 medical institutions were included. LUTS were assessed in all patients using the International Prostate Symptom Score (IPSS), and PMD was assessed using the HPMDQ.


In total, 2134 male patients aged 40 to 91 years were included in this study. Of these patients, 1088 (51.0%) reported PMD. In the PMD group, the mean values for HPMDQ-Q1, HPMDQ-Q2, HPMDQ-Q3 and HPMDQ total score were 1.39, 1.10, 1.76 and 4.25, respectively. In the non-PMD group, the mean values of these scores were 0, 0.18, 1.52 and 1.58, respectively. The difference in HPMDQ scores between the 2 groups was statistically significant. PMD was significantly associated with the voiding symptoms of LUTS, prostate size and postvoid residual but not with storage symptoms.


The HPMDQ, which consists of 5 questions (frequency, severity, bother, quality of life and response to treatment for PMD), was developed, and its use for assessing PMD is validated in this study. It may be a useful tool for further research and in clinical practice for PMD.

Klíčová slova:

Bladder – Chi square tests – Prostate gland – Quality of life – Questionnaires – Urine – Urology – Urination


1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. 2003; Urology. 61: 37–49. doi: 10.1016/s0090-4295(02)02243-4 12559262

2. Stephenson TP, Farrar DJ. Urodynamic study of 15 patients with PMD. Urology. 1977; 9: 404–6. doi: 10.1016/0090-4295(77)90216-3 558674

3. Wille S, Mills RD, Studer UE. Absence of urethral post-void milking: an additional cause for incontinence after radical prostatectomy? Eur. Urol. 2000; 37: 665–9. doi: 10.1159/000020215 10828665

4. Pöyhönen A, Auvinen A, Koskimäki J, Hakama M, Tammela TL, Häkkinen JT. Prevalence and bother of PMD in Finnish men aged 30–80 years: Tampere Ageing Male Urologic Study (TAMUS). Scand. J. Urol. Nephrol. 2012; 46: 418–23. doi: 10.3109/00365599.2012.702786 22835055

5. Häkkinen JT, Hakama M, Huhtala H, Shiri R, Auvinen A, Tammela TL et al. Impact of LUTS using bother index in DAN-PSS-1 questionnaire. Eur. Urol. 2007; 51: 473–7. doi: 10.1016/j.eururo.2006.06.011 16879907

6. Pöyhönen A, Auvinen A, Häkkinen JT, Koskimäki J, Tammela TL. Population-level and Individual-level Bother of Lower Urinary Tract Symptoms Among 30- to 80-year-old Men. Urology. 2016; 95: 164–70. doi: 10.1016/j.urology.2016.06.023 27349526

7. Maserejian NN, Kupelian V, McVary KT, Doshi M, Link CL, McKinlay JB. Prevalence of post-micturition symptoms in association with lower urinary tract symptoms and health-related quality of life in men and women. BJU. Int. 2011; 108: 1452–8. doi: 10.1111/j.1464-410X.2010.10014.x 21223471

8. Irwin DE1, Milsom I, Kopp Z, Abrams P, Artibani W, Herschorn S. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur. Urol. 2009; 56: 14–20. doi: 10.1016/j.eururo.2009.02.026 19278775

9. Kim TH, Han DH, Lee KS. The prevalence of lower urinary tract symptoms in korean men aged 40 years or older: a population-based survey. Int. Neurourol. J. 2014; 18: 126–32. doi: 10.5213/inj.2014.18.3.126 25279239

10. Agarwal A, Eryuzlu LN, Cartwright R, Thorlund K, Tammela TL, Guyatt GH et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur. Urol. 2014; 65: 1211–7. doi: 10.1016/j.eururo.2014.01.019 24486308

11. Barry MJ, Fowler FJ Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J. Urol. 1992; 148: 1549–57. doi: 10.1016/s0022-5347(17)36966-5 1279218

12. Lee H, Jeong SJ. Epidemiology of lower urinary tract symptoms: emphasis on the status in Korea. Korean. J. Urol. 2014; 55: 300–8. doi: 10.4111/kju.2014.55.5.300 24868333

13. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur. Urol. 2006; 50: 1306–14. doi: 10.1016/j.eururo.2006.09.019 17049716

14. Koskimäki J, Hakama M, Huhtala H, Tammela TL. Prevalence of lower urinary tract symptoms in Finnish men: a population-based study. Br. J. Urol. 1998; 81: 364–9. doi: 10.1046/j.1464-410x.1998.00565.x 9523653

15. Malmsten UG1, Milsom I, Molander U, Norlén LJ. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J. Urol. 1997; 158: 1733–7. doi: 10.1016/s0022-5347(01)64113-2 9334589

16. Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, ZS Kopp, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU. Int. 2009; 104: 352–60. doi: 10.1111/j.1464-410X.2009.08427.x 19281467

17. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand. J. Urol. Nephrol. Suppl. 1991; 138: 59–62. 1723812

18. Engström G1, Walker-Engström ML, Henningsohn L, Lööf L, Leppert J. Prevalence of distress and symptom severity from the lower urinary tract in men: a population-based study with the DAN-PSS questionnaire. Fam. Pract. 2004; 21: 617–22.

Článek vyšel v časopise


2019 Číslo 10